While these results must be treated with caution, the analysis shows semaglutide can be an effective tool to treat this advanced liver disease. The trials findings, published Wednesday in the New England Journal of Medicine, are almost certain to secure the drugs approval for treating MASH from the Food and Drug Administration
A review describing GLP-1 drugs as promising but unproven for alcohol and substance use concludes that approved treatments should be used until safety and efficacy are demonstrated in dedicated trials
If you experience side effects like nausea, dizziness, or fatigue, your provider may hold your dosage at a lower level until your body adapts
doi:10.1007/s10517-011-1332-x
Forneris, F., Orru, R., Bonivento, D., Chiarelli, L
Its often a companion on a stressful workday, and it even gives energy when you are hit by fatigue